Trials / Completed
CompletedNCT02104921
Innovative Ultrasound Technology in Neuromuscular Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 223 (actual)
- Sponsor
- Beth Israel Deaconess Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
This study is utilizing ultrasound measurement to measure neuromuscular disease status in adult patients. The hypothesis is the by quantifying ultrasound data, it is possible that ultrasound can be utilized as a tool to determine if a disease is responding to therapy or progressing.
Conditions
- Amyotrophic Lateral Sclerosis
- Muscular Dystrophy
- Radiculopathy
- Myopathy
- Polyneuropathy and Mononeuropathies
- Trauma Injury
- Orthopedic Disorder
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2020-03-01
- Completion
- 2020-03-01
- First posted
- 2014-04-07
- Last updated
- 2022-03-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02104921. Inclusion in this directory is not an endorsement.